ScholarIQanswers from OpenAlex & ORCID
Ran Duan
ResearcherPublications, citations & collaboration network
Ran Duan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ran Duan have?
ScholarIQindexed works
Ran Duan has 40 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ran Duan have?
ScholarIQcitation count
Ran Duan has 323 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ran Duan?
ScholarIQh-index
Ran Duan has an h-index of 12 in OpenAlex.
What is the i10-index of Ran Duan?
ScholarIQi10-index
Ran Duan has an i10-index of 13 in OpenAlex.
What is the ORCID of Ran Duan?
ScholarIQorcid
The ORCID for Ran Duan is on the source record.
What is the OpenAlex record for Ran Duan?
ScholarIQopenalex
The OpenAlex for Ran Duan is on the source record.
What are the most-cited papers on Ran Duan?
ScholarIQmost cited works
Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US
Magaly Perez‐Nieves, Samaneh Kabul, Urvi Desai, Jasmina Ivanova, Noam Y. Kirson, Alice Kate G. Cummings, Howard G. Birnbaum, Ran Duan, Dachuang Cao, Irene Hadjiyianni
Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
Ran Duan, Xiaoqin Li, Dongqiang Zeng, Xiaofeng Chen, Bo Shen, Dongqin Zhu, Liuqing Zhu, Yangyang Yu, Deqiang Wang
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
Xiaowei Zhang, Ran Duan, Yusheng Wang, Xin Liu, Wen Zhang, Xiaodong Zhu, Zhiyu Chen, Wei Feng Shen, Yifu He, Hongqiang Wang, Mingzhu Huang, Chenchen Wang, Zhe Zhang, Xiaoying Zhao, Li‐Xin Qiu, Jianfeng Luo, Xuedan Sheng, Weijian Guo
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
Samaneh Kabul, Robert C. Hood, Ran Duan, Amy M. DeLozier, Julie Settles
Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )
Simon Heller, Richard E. Pratley, Alan J. Sinclair, Andreas Festa, Jacek Kiljański, Cynthia Brusko, Ran Duan, Robert J. Heine